|
 |
| CASE REPORT |
|
|
|
| Year : 2013 | Volume
: 28
| Issue : 1 | Page : 34-35 |
|
|
Skeletal muscle metastases as the initial manifestation of an unknown primary lung cancer detected on F-18 fluorodeoxyglucose positron emission tomography/computed tomography
Kanhaiyalal Agrawal1, Anish Bhattacharya1, Navneet Singh2, Chidambaram Natarajan Balasubramanian Harisankar1, Bhagwant Rai Mittal1
1 Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
2 Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
| Date of Web Publication | 22-Aug-2013 |
Correspondence Address:
Anish Bhattacharya
Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh - 160 012
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-3919.116814
 Abstract | | |
Skeletal muscle metastasis as the initial presentation of the unknown primary lung cancer is unusual. A 65-year-old male patient presented with pain and swelling of the right forearm. Fine needle aspiration of the swelling revealed metastatic squamous cell carcinoma. The patient underwent whole body F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) to identify the site of the primary malignancy. The authors present PET/ CT images showing FDG-avid metastases to the skeletal muscles along with a previously unknown primary tumor in the right lung, in a patient presenting with initial muscular symptoms without any pulmonary manifestations. Keywords: F-18 fluorodeoxyglucose, lung cancer, metastases, muscle, positron emission tomography/computed tomography
How to cite this article:
Agrawal K, Bhattacharya A, Singh N, Harisankar CN, Mittal BR. Skeletal muscle metastases as the initial manifestation of an unknown primary lung cancer detected on F-18 fluorodeoxyglucose positron emission tomography/computed tomography. Indian J Nucl Med 2013;28:34-5 |
How to cite this URL:
Agrawal K, Bhattacharya A, Singh N, Harisankar CN, Mittal BR. Skeletal muscle metastases as the initial manifestation of an unknown primary lung cancer detected on F-18 fluorodeoxyglucose positron emission tomography/computed tomography. Indian J Nucl Med [serial online] 2013 [cited 2022 Aug 13];28:34-5. Available from: https://www.ijnm.in/text.asp?2013/28/1/34/116814 |
| Introduction | |  |
Skeletal muscle metastasis as the initial presentation of an unknown primary lung cancer is unusual. F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging is useful in the identification of primary in carcinoma of unknown origin. We describe a patient showing FDG-avid metastases to the skeletal muscles along with a previously unknown primary tumor in the right lung, in a patient presenting with initial muscular symptoms without any pulmonary manifestations.
| Case Report | | |
A 65-year-old male presented with pain and swelling of the right forearm. Fine needle aspiration cytology of the swelling showed metastatic squamous cell carcinoma. The patient underwent a whole body F-18 FDG PET/CT to identify the site of the primary malignancy. Increased FDG avidity (standardized uptake value [SUV max ] 9.0) was detected in an irregular heterogeneously enhancing soft-tissue mass in the right paravertebral region in the upper lobe of the right lung with a focus of calcification within the mass [Figure 1]b and d, white arrow]. Abnormal FDG uptake was also noted in a presacral mass [Figure 1]c and e, the bulky left adrenal gland, several dorsal vertebrae and multiple lesions in the trapezius [Figure 1]b and d, red arrow], right brachioradialis [Figure 2], deltoid, and right external oblique muscles [Figure 3], suggestive of metastatic involvement. A diagnosis of primary squamous cell carcinoma of the lung was pathologically confirmed. The patient was treated with 4 cycles of chemotherapy, after which significant decrease in FDG uptake (SUV max = 5.1) was seen in the primary as well as the right brachioradialis muscle lesion (not shown here). | Figure 1: Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) Maximum intensity projection (MIP) image (a) showing multiple foci of abnormal tracer uptake. Transaxial thoracic CT (b) and fused PET/CT image (d) show increased FDG uptake in an irregular, heterogeneously enhancing soft-tissue mass (white arrow) in the paravertebral region in the upper lobe of the right lung with calcification within the mass. Increased FDG uptake is also seen in a peripherally enhancing ring like lesion in the trapezius (red arrow). Axial CT (c) and fused PET/CT (e) images at the level of the rectum show increased FDG uptake in a heterogeneously enhancing pre-sacral soft-tissue deposit
Click here to view |
 | Figure 2: Coronal and transaxial computed tomography (CT) (a and c) and fused positron emission tomography/CT (b and d) images of the right hand showing increased fluorodeoxyglucose uptake in the right brachioradialis muscle with no increase in attenuation (probably because the images were acquired after completion of the whole body PET scan)
Click here to view |
 | Figure 3: Axial computed tomography (a) and fused positron emission tomography/computed tomography (b) images showing increased tracer uptake in a ring-like hyperenhancing lesion in the right external oblique muscle suggestive of muscle metastasis
Click here to view |
| Discussion | | |
Skeletal muscles are uncommon site of hematogenous metastases from epithelial neoplasms. Solitary muscle metastasis has been previously reported in lung cancer. [1] Tuoheti et al. found that only 4 patients (0.16%) among 2,557 patients with lung cancer developed metastasis to the skeletal muscle. [2] Most frequent muscle involvement is seen in the thigh, iliopsoas and paraspinous muscles. [3] Whole-body FDG PET/CT imaging is useful in detection of muscle metastases in lung cancer patients. [4] Multiple muscle metastases from lung cancer are rare, and FDG PET/CT imaging is useful in the identification of unsuspected metastatic sites. [5] Primary presentation of a skeletal muscle metastasis, such as in our case, remains an unusual occurrence. [3],[6],[7],[8],[9] The present case, where the initial presentation was of metastatic muscular involvement, highlights the role of FDG PET/CT in tracing the location of primary lung malignancy and unsuspected sites of multiple muscle metastases in a patient with muscle metastases of unknown primary.
| References | | |
| 1. | Di Giorgio A, Sammartino P, Cardini CL, Al Mansour M, Accarpio F, Sibio S, et al. Lung cancer and skeletal muscle metastases. Ann Thorac Surg 2004;78:709-11. 
[PUBMED] |
| 2. | Tuoheti Y, Okada K, Osanai T, Nishida J, Ehara S, Hashimoto M, et al. Skeletal muscle metastases of carcinoma: A clinicopathological study of 12 cases. Jpn J Clin Oncol 2004;34:210-4.
[PUBMED] |
| 3. | Kaira K, Ishizuka T, Yanagitani N, Sunaga N, Tsuchiya T, Hisada T, et al. Forearm muscle metastasis as an initial clinical manifestation of lung cancer. South Med J 2009;102:79-81.
[PUBMED] |
| 4. | Bhargava P, Verstovsek G, Stair M, Vollink J. Metastasis to psoas muscle detected by F-18 FDG PET-CT imaging. Clin Nucl Med 2008;33:723-4.
[PUBMED] |
| 5. | Yilmaz M, Elboga U, Celen Z, Isik F, Tutar E. Multiple muscle metastases from lung cancer detected by FDG PET/CT. Clin Nucl Med 2011;36:245-7.
[PUBMED] |
| 6. | Loziæ AA, Silconi ZB, Misljenoviæ N. Metastases to rare locations as the initial manifestation of non-small cell lung cancer: Two case reports. Coll Antropol 2010;34:609-12.
|
| 7. | Ruzzini L, Rigato P, Ruzzini S. Intramuscular forearm metastasis as an initial presentation of bronchial adenocarcinoma. Acta Orthop Belg 2009;75:129-32.
[PUBMED] |
| 8. | Singh A, Pandey KC, Pant NK. Cavitary mucoepidermoid carcinoma of lung with metastases in skeletal muscles as presenting features: A case report and review of the literature. J Cancer Res Ther 2010;6:350-2.
[PUBMED] |
| 9. | Razak AR, Chhabra R, Hughes A, England S, Dildey P, McMenemin R. Muscular metastasis, a rare presentation of non-small-cell lung cancer. MedGenMed 2007;9:20.
|
[Figure 1], [Figure 2], [Figure 3]
|
